← Leaderboards
Ype Peter De Jong
Indiana University Indianapolis
$6,364,069
Attributed
$10,717,692
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,717,692 · 5
By mechanism
R01$8,437,309 · 2
P01$1,520,873 · 2
K08$759,510 · 1
Top collaborators
- Roland W. Herzog9 shared
- Cornelis P Terhorst8 shared
- Jamie Berta Spangler1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Zeruesenay Desta$10,598,664
- Roland W. Herzog$25,146,618
- Jing Ma$543,404
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverHepatocyteCellsIn VivoResponseMouse ModelImmune ResponseViralImmuneIn VitroBaseProtocols DocumentationImmune ActivationOverexpressionImmunodeficient MouseAnimalsHemophilia AGene TherapyClinical TrialsGene TransferHepaticImmune SystemVectorViral Genes
Grant awards (23)
Enhancing immune regulation in gene therapy for hemophilia$745,423
R01 · FY2025 · HL
Human Hepatocyte and Discovery Core$354,301
P01 · FY2025 · HL · contact PI
Enhancing immune regulation in gene therapy for hemophilia$704,157
R01 · FY2024 · HL
Human Hepatocyte and Discovery Core$360,515
P01 · FY2024 · HL · contact PI
Enhancing immune regulation in gene therapy for hemophilia$724,174
R01 · FY2023 · HL
Human Hepatocyte and Discovery Core$400,571
P01 · FY2023 · HL · contact PI
Modeling alcohol toxicity in human hepatocytes$381,375
R01 · FY2023 · AA · contact PI
Enhancing immune regulation in gene therapy for hemophilia$729,657
R01 · FY2022 · HL
Human Hepatocyte and Discovery Core$405,486
P01 · FY2022 · HL · contact PI
Modeling alcohol toxicity in human hepatocytes$381,375
R01 · FY2022 · AA · contact PI
Enhancing immune regulation in gene therapy for hemophilia$761,303
R01 · FY2021 · HL
Modeling alcohol toxicity in human hepatocytes$381,375
R01 · FY2021 · AA · contact PI
Modeling alcohol toxicity in human hepatocytes$381,375
R01 · FY2020 · AA · contact PI
Enhancing immune regulation in gene therapy for hemophilia$696,357
R01 · FY2019 · HL
Modeling alcohol toxicity in human hepatocytes$381,375
R01 · FY2019 · AA · contact PI
Enhancing immune regulation in gene therapy for hemophilia$708,753
R01 · FY2018 · HL
Enhancing immune regulation in gene therapy for hemophilia$715,056
R01 · FY2017 · HL
Enhancing immune regulation in gene therapy for hemophilia$745,554
R01 · FY2016 · HL
The role of innate immune evasion in hepatitis C virus infection$151,902
K08 · FY2015 · DK · contact PI
The role of innate immune evasion in hepatitis C virus infection$151,902
K08 · FY2014 · DK · contact PI
The role of innate immune evasion in hepatitis C virus infection$151,902
K08 · FY2013 · DK · contact PI
The role of innate immune evasion in hepatitis C virus infection$151,902
K08 · FY2012 · DK · contact PI
The role of innate immune evasion in hepatitis C virus infection$151,902
K08 · FY2011 · DK · contact PI